XML 41 R31.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 14 - Research and Development Expenses (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Notes Tables |
Schedule of Research and Development Expenses [Table Text Block] |
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Salary and employee benefits |  | $ | 711 |  |  | $ | 317 |  |  | $ | 1,154 |  |  | $ | 571 |
Consultants and subcontractors |  |  | 100 |  |  |  | 25 |  |  |  | 177 |  |  |  | 48 |
Depreciation |  |  | 4 |  |  |  | - |  |  |  | 8 |  |  |  | - |
Clinical trials |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 19 |
Expenses - other |  |  | 63 |  |  |  | 50 |  |  |  | 178 |  |  |  | 74 |
Total |  | $ | 878 |  |  | $ | 392 |  |  | $ | 1,517 |  |  | $ | 712 |

X
- Definition Tabular disclosure of the entity's research and development costs. + References No definition available. + Details
Name: | aiff_ScheduleOfResearchAndDevelopmentExpensesTableTextBlock
Namespace Prefix: | aiff_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration